Key result
Noninvasive cardiac imaging aids risk stratification and reduces unnecessary invasive angiograms in stable CAD.
Answers are grounded in this paper and cite their sources.
The aim of this review was to discuss the current literature regarding the utility of noninvasive imaging in diagnosis and management of stable coronary artery disease (CAD) including recent data from large randomized trials assessing diagnosis and prognosis. Current guidelines recommend revascularization in patients with refractory angina and in those with potential prognostic benefit. Appropriate risk stratification through noninvasive assessment is important in ensuring patients are not exposed to unnecessary invasive coronary angiograms. The past 20 years have seen an unprecedented expansion in noninvasive imaging modalities for the assessment of stable CAD, with cardiovascular magnetic resonance and computed tomography complementing established techniques such as myocardial perfusion imaging, echocardiography and exercise electrocardiogram. In this review, we examine the current state-of-the-art in noninvasive imaging to provide an up-to-date analysis of current investigation and management options.
No takes yet. Share an insight, caveat, or question.
Mordi et al. (2017) conducted a review in Stable coronary artery disease. Noninvasive cardiac imaging (cardiovascular magnetic resonance, computed tomography, myocardial perfusion imaging, echocardiography, and exercise electrocardiogram) vs. Invasive coronary angiography was evaluated. Noninvasive cardiac imaging modalities have expanded over the past 20 years to aid risk stratification and reduce unnecessary invasive coronary angiograms in stable coronary artery disease.
Synapse has enriched 10 related papers. Consider them for comparative context: